By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Audubon Business and Technology Center
Columbia University Medical Center

3960 Broadway, Suite 440C
New York  New York  10032  U.S.A.
Phone: 212-568-0365 Fax: 212-568-0469


Start Up

Company News
OLIGOMERIX To Present Its Drug Discovery Program Targeting Tau Oligomers At The Federation Of European Neuroscience Societies Forum And The Alzheimer's Association International Conference® 6/30/2014 9:07:32 AM
OLIGOMERIX To Present At Biotech Showcase™ 2014 1/7/2014 8:41:47 AM
Taconic And OLIGOMERIX To Collaborate On Tau Mouse Model Characterization For Use In Alzheimer's Disease Research 12/9/2013 11:12:28 AM
OLIGOMERIX Awarded Phase IIB Grant From the NIH to Discover Drugs That Inhibit Alzheimer's Disease Progression 9/10/2013 10:50:16 AM
OLIGOMERIX Release: Identification of a Tau Oligomer Structure That is Toxic to Neurons Published in the International Journal of Cell Biology 9/4/2013 10:43:56 AM
OLIGOMERIX Announces Addition of Industry Veteran James Hendrix, Ph.D., to Serve as Senior Director of Chemistry 7/16/2013 10:05:23 AM
OLIGOMERIX to Present Multiple Posters Highlighting its Tau-Focused Technology During the Annual Alzheimer's Association International Conference® 7/9/2013 6:34:53 AM
OLIGOMERIX Completes Series B Financing 5/22/2013 10:22:49 AM
OLIGOMERIX Completes $2 Million Series A Financing 4/23/2012 10:25:33 AM
A New Mechanism for Tau Protein Pathology in Alzheimer's Disease was Presented by OLIGOMERIX at the Society For Neuroscience Annual Meeting 11/17/2011 11:43:47 AM